Clinical effectiveness, safety and viral mutagenicity of oral favipiravir for COVID-19: Results from a phase II/III trial. - Vienna 2024

Respiratory infection: from bench to bedside

Chair(s): Thomas Wilkinson, Lydia Finney

Session type: Oral presentation

Clinical effectiveness, safety and viral mutagenicity of oral favipiravir for COVID-19: Results from a phase II/III trial.

Kevin Blyth

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Public health impact of adjuvanted RSVPreF3 vaccination of older adults in six Latin American countries

Adriana Guzman Holst

Replay

Poster

Abstract

Slides

Adjuvancy effects of a RIG-I agonist (RIG101) on H1N1 HA antigen intranasally vaccinated mice and human nasal epithelium/PBMCs co-culture

Shyreen Hassibi

Replay

Poster

Abstract

Slides

Molecular Mechanisms of DNase Inhibition of Early Biofilm Formation Pseudomonas aeruginosa or Staphylococcus aureus: A Transcriptome Analysis

Qin Jiaoxia

Abstract

Lung and gut microbiota are associated with long-term pulmonary function recovery after severe COVID-19: a 1-year follow-up study

Sabine Stadler

Replay

Poster

Abstract

Slides

Gut Eggerthella lenta aggravates chronic pulmonary infection through taurine ursodeoxycholic acid induced neutrophil dysfunction

Lele Wang

Replay

Poster

Abstract

Slides

Respiratory Infections Prediction via Wearable Sensors: A Machine Learning Approach

Yibing Chen

Poster

Abstract

Slides

Single-cell analysis of Mucosal Associated Invariant T cells in influenza A virus infection

Timothy Hinks

Replay

Poster

Abstract

Slides

Clinical effectiveness, safety and viral mutagenicity of oral favipiravir for COVID-19: Results from a phase II/III trial.

Kevin Blyth

Replay

Poster

Abstract

Slides

Clinical characteristics of patients one year after hospitalisation for viral lower respiratory tract disease: A descriptive US claims analysis

Ekaterina Maslova

Replay

Poster

Abstract

Slides

CFTR modulator therapy does not alter breath profiles in cystic fibrosis

Elias Seidl

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}